Medical Director, Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease

Research Interest

Dr. Gibson’s research focuses on clinical pathogenesis interstitial lung diseases including idiopathic pulmonary fibrosis, Sarcoidosis, autoimmune lung disease, and Occupational lung disease. Dr. Gibson conducts studies that include early and late phase clinical trials of novel therapeutics in interstitial lung disease, the discovery of biomarkers of disease activity and progression, and clinical translational studies of disease pathogenesis. He has published a number of translational studies to identify unique biomarkers of disease activity in idiopathic pulmonary fibrosis and other interstitial lung diseases, studies of novel interventions in acute IPF exacerbations, as well as studies of gene expression profiling in IPF lungs. He has discovered a number of peripheral blood biomarkers that have been useful predicting disease progression in idiopathic pulmonary fibrosis. He has participated in multinational Studies of the genetics of IPF and Sarcoidosis.

Clinical Interest

Dr. Gibson is the medical director of the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease. He is in charge of all clinical research in the center and has an active consultative practice focusing on all of the diffuse parenchymal lung diseases including the idiopathic interstitial pneumonias, autoimmune lung diseases, hypersensitivity pneumonitis, genetic-based interstitial lung diseases, and Sarcoidosis. He is principal investigator on a large number of government-sponsored and industry-funded clinical trials of novel therapeutic agents and therapeutic approaches to disease such as idiopathic pulmonary fibrosis, Sarcoidosis, and pulmonary fibrosis from secondary causes.